Showing 581-590 of 2386 results for "".
Neuroimaging Biomarkers in Alzheimer Disease and Related Dementias: From Structural MRI to Amyloid and Tau PET
https://practicalneurology.com/diseases-diagnoses/imaging-testing/neuroimaging-biomarkers-in-alzheimer-disease-and-related-dementias-from-structural-mri-to-amyloid-and-tau-pet/56376/This practical guide explains how multimodal neuroimaging refines the diagnosis of Alzheimer disease, frontemporal dementia, dementia with Lewy bodies, and vascular dementia.- Therapeutics Q&Ahttps://practicalneurology.com/columns/practice-management/therapeutics-qa/31019/Optimizing Restless Legs Syndrome Treatment: Insights from Recent Meta-Analysis and Clinical ExperiencesA recent meta-analysis evaluating the side effects and wearing-off effects of four Restless Legs Syndrome (RLS) medications highlighted significant findings relevant to clinical practice. The stud
- Second Opinionshttps://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/PN0505SecondOpinion-pdf/31458/Addressing the AD-VaD Diagnostic Challenge in NeurologyIn the debate surrounding Alzheimer’s Disease (AD) versus vascular dementia (VaD) diagnosis, Dr. Geldmacher’s April 2005 article, “Diagnosing Alzheimer’s: Easy Answers vs. Right Answers,” ignited significant discourse. Dr. Geldmacher critiques c
Meningeal Enhancement Seen on Workup for Memory Loss
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/meningeal-enhancement-seen-on-workup-for-memory-loss/30222/Inflammation in the context of memory loss reminds us of the importance of checking opening pressure on lumbar puncture.Relapsing and Progressive Multiple Sclerosis: Understanding the Differences
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/relapsing-and-progressive-multiple-sclerosis-understanding-the-differences/30761/Accurate diagnosis is important in order to adjust treatment according to MS type as wells as individual response.Pay for Performance: Understanding and Preparing for MIPS
https://practicalneurology.com/columns/practice-management/pay-for-performance-understanding-and-preparing-for-mips/30418/As a new reimbursement model is set to unveil, physicians will have a tight window to prepare their practices to begin reporting in 2017.Update on Refractory Status Epilepticus
https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/update-on-refractory-status-epilepticus/30758/The first priority for the consulting neurologist is confirming the diagnosis. Treating any underlying disease does far more to improve outcome than mere suppression of seizures. Treatment options exist for prolonged SE, but clinicians must be realistic with families.Onabotulinumtoxin A for Headache: An Update
https://practicalneurology.com/diseases-diagnoses/headache-pain/onabotulinumtoxin-a-for-headache-an-update/30783/A year after FDA approval, a specialist offers an update on neurotoxin therapy for migraine and headache.Sexual Discomfort: Dealing with Dysfunction in MS and Other Neurological Conditions
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/PN0509_01-php/30915/Sexual dysfunction can be detrimental to patients with neurodegenerative disease—especially MS. So why aren't patients—and neurologists—talking more about it?Board Re-Certification: Reform or Reboot
https://practicalneurology.com/columns/practice-management/board-re-certification-reform-or-reboot/30542/A neurologist has been leading the charge to reform MOC in neurology. He talked to Practical Neurology® about the issue.